Pfizer And Auxilium Announce Commencement Of European Regulatory Review Of XIAFLEXTM For The Treatment Of Dupuytren's Contracture
Pfizer Inc. (NYSE: PFE) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that Pfizer received notification from the European Medicines Agency that the Marketing Authorization Application (MAA) for XIAFLEX™ (collagenase clostridium ....
Sun Jan 2010 08:01 (7 months, 2 weeks ago)
Medical News Today 48434 articles in collection Read Full Article | Share with Friend
Related articles
-
6 months
after
-
5 months
after
-
4 months
after- Pfizer Statement On Conducting Clinical Trial - Medical News Today
- Pfizer Oncology To Present New Clinical Data From Ten Molecules Across Multiple Tumor Types - Medical News Today
-
3 months
after
-
1 month
after- Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer - Medical News Today
- Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine) Alzheimer's Disease Clinical Development Program - Medical News Today
- CDC's Advisory Committee On Immunization Practices Recommends Pfizer's Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Disease - Medical News Today
- Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children - Medical News Today
-
1 week
after
-
4 days
after
-
Selected Article Pfizer And Auxilium Announce Commencement Of European Regulatory Review Of XIAFLEXTM For The Treatment Of Dupuytren's Contracture - Medical News Today
-
4 days
before- Pfizer/Auxilium’s contracted hand drug set for EU review - PharmaTimes
-
1 month
before- Pfizer Announces Neratinib Data In HER2 Positive Breast Cancer - Medical News Today
- Pfizer Receives European Authorization For Prevenar 13 For The Prevention Of Pneumococcal Disease In Infants And Young Children - Medical News Today
- Pfizer links up with Protalix, outlines generics plan for Japan - PharmaTimes
-
2 months
before- Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults - Medical News Today
- Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA) - Medical News Today
- Pfizer Inc : Pfizer Submits New Pediatri... - Investegate
-
3 months
before- Pfizer Inc : Pfizer Reports Third-Quarte... - Investegate
-
4 months
before
-
5 months
before
-
6 months
before- Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth - Medical News Today
- Pfizer Inc : Pfizer Reports Second-Quart... - Investegate
Organisations mentioned
Article Profile
| Sentiment | |
|---|---|
| Access | Publicly available |
| Audio | No |
| Video | No |